Deflazacort, a steroid, can be purchased online from non-US sources for $1.00, but now it's being marketed by Illinois's Marathon Pharmaceuticals for $89,000 as Emflaza, to treat Duchenne muscular dystrophy, which predominantly affects men in their 20s.
The drug's never been approved in the US, and Marathon has a special dispensation to market it for the rare disease, so it gets to name its price.
In many ways, Marathon is taking a page from Shkreli's playbook. By bringing a drug that's been well-established as safe in other markets to the U.S. for the first time in order to treat a rare disease, the company doesn't just control its pricing destiny — it will also receive a coveted "priority review voucher" which it can hawk to another firm for tens (or even hundreds) of millions of dollars. If not, the company can use it to expedite a future drug approval in order to gain a first-to-market advantage.
In fact, one of Marathon's clinical trials that the FDA used as part of its decision-making process was conducted more than 20 years ago, saving the firm plenty of study costs.
Duchenne drugs have fostered recent controversy in the U.S. Last year, the FDA approved a pioneering Duchenne treatment from Sarepta Therapeutics (SRPT, -5.15%) over the protests of its own scientific advisers who said it lacked proven efficacy. Unlike Sarepta, Marathon's product doesn't actually address the protein deficiency at the heart of the disease, but rather has shown promise in improving muscle strength.
This Pharma Company Is Selling a Decades-old Drug to Treat Muscular Dystrophy for $89,000
When United CEO Oscar Munoz lied about Dr David Dao, slandering the passenger that was beaten unconscious as a direct result of his employees enacting the policies he put in place, he was acting in the knowledge that he would shortly be elevated to the Chairmanship of United’s board of directors.
Motherboard’s Joseph Cox continues his excellent reporting on Flexispy, a company that make “stalkerware” marketed to jealous spouses through a network of shady affiliates who feature dudes beating up their “cheating girlfriends” after catching them by sneaking spyware onto their devices.
In Canada’s hyper-concentrated and vertically integrated telcoms sector, data caps are a normal part of life; and where there are data-caps, there is cable company fuckery in the form of “”zero rating” — when your telcom sells you to online service providers, taking bribes not to count their service against your cap.
They probably just sleep a lot. But still, you can remotely keep an eye on them when you’re at work and missing them deeply with this HD monitor from Kodak.If you have a new puppy that destroys everything in sight, or you just want to be a little more security-conscious, this WiFi camera is a […]
Thinking of a business idea is the easy part. Doesn’t even have to be a “good” idea, you can still get people to throw money at a non-existent venture, but to do that you need to at least have something even resembling a viable business plan. Why doesn’t anyone do it then? Because building that semi-viable […]
The Twisty Glass Blunt is an intriguing product that claims to abolish the need to ever buy or use rolling papers. And, well, it does if you so choose. You can cut down on the waste this 4/20, and everyday after when you’re smoking with this clever piece.Built with a German-engineered glass tube and inner […]